Aclaris: Q1 Earnings Snapshot
By Ap News
Published - May 07, 2024, 04:27 PM ET
Last Updated - May 27, 2024, 01:01 AM EDT
WAYNE, Pa. (AP) — WAYNE, Pa. (AP) — Aclaris Therapeutics Inc. (ACRS) on Tuesday reported a loss of $16.9 million in its first quarter.
The Wayne, Pennsylvania-based company said it had a loss of 24 cents per share.
The results beat Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 28 cents per share.
The specialty pharmaceutical company posted revenue of $2.4 million in the period, which also topped Street forecasts. Five analysts surveyed by Zacks expected $2 million.
